Circumferential pulmonary-vein ablation for chronic atrial fibrillation
- PMID: 16510747
- DOI: 10.1056/NEJMoa050955
Circumferential pulmonary-vein ablation for chronic atrial fibrillation
Abstract
Background: We conducted a randomized, controlled trial of circumferential pulmonary-vein ablation for the treatment of chronic atrial fibrillation.
Methods: A total of 146 patients with a mean (+/-SD) age of 57+/-9 years who had chronic atrial fibrillation were randomly assigned to receive amiodarone and undergo two cardioversions during the first three months alone (the control group) or in combination with circumferential pulmonary-vein ablation. Cardiac rhythm was assessed with daily telephonic transmissions for one year. The left atrial diameter and the severity of symptoms were assessed at 12 months.
Results: Among the 77 patients assigned to undergo circumferential pulmonary-vein ablation, ablation was repeated because of recurrent atrial fibrillation in 26 percent of patients and atypical atrial flutter in 6 percent. An intention-to-treat analysis showed that 74 percent of patients in the ablation group and 58 percent of those in the control group were free of recurrent atrial fibrillation or flutter without antiarrhythmic-drug therapy at one year (P=0.05). Among the 69 patients in the control group, 53 (77 percent) crossed over to undergo circumferential pulmonary-vein ablation for recurrent atrial fibrillation by one year and only 3 (4 percent) were in sinus rhythm without antiarrhythmic-drug therapy or ablation. There were significant decreases in the left atrial diameter (12+/-11 percent, P<0.001) and the symptom severity score (59+/-21 percent, P<0.001) among patients who remained in sinus rhythm after circumferential pulmonary-vein ablation. Except for atypical atrial flutter, there were no complications attributable to circumferential pulmonary-vein ablation.
Conclusions: Sinus rhythm can be maintained long term in the majority of patients with chronic atrial fibrillation by means of circumferential pulmonary-vein ablation independently of the effects of antiarrhythmic-drug therapy, cardioversion, or both. The maintenance of sinus rhythm is associated with a significant decrease in both the severity of symptoms and the left atrial diameter.
Copyright 2006 Massachusetts Medical Society.
Comment in
-
Catheter ablation of chronic atrial fibrillation--the gap between promise and practice.N Engl J Med. 2006 Mar 2;354(9):967-9. doi: 10.1056/NEJMe058310. N Engl J Med. 2006. PMID: 16510752 No abstract available.
-
Circumferential pulmonary-vein ablation for atrial fibrillation.N Engl J Med. 2006 May 25;354(21):2289-91; author reply 2289-91. doi: 10.1056/NEJMc060884. N Engl J Med. 2006. PMID: 16723624 No abstract available.
-
Circumferential pulmonary-vein ablation for atrial fibrillation.N Engl J Med. 2006 May 25;354(21):2289-91; author reply 2289-91. N Engl J Med. 2006. PMID: 16729369 No abstract available.
-
Circumferential pulmonary-vein ablation for atrial fibrillation.N Engl J Med. 2006 May 25;354(21):2289-91; author reply 2289-91. N Engl J Med. 2006. PMID: 16729370 No abstract available.
Similar articles
-
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.J Am Coll Cardiol. 2006 Dec 5;48(11):2340-7. doi: 10.1016/j.jacc.2006.08.037. Epub 2006 Oct 16. J Am Coll Cardiol. 2006. PMID: 17161267 Clinical Trial.
-
Catheter ablation of persistent atrial fibrillation : Beneficial effect of a short-term adjunctive amiodarone therapy on the long-term outcome.Herzschrittmacherther Elektrophysiol. 2018 Mar;29(1):133-140. doi: 10.1007/s00399-017-0498-y. Epub 2017 Apr 26. Herzschrittmacherther Elektrophysiol. 2018. PMID: 28447159 Clinical Trial. English.
-
Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.Circulation. 2003 Nov 18;108(20):2479-83. doi: 10.1161/01.CIR.0000101684.88679.AB. Epub 2003 Nov 10. Circulation. 2003. PMID: 14610012 Clinical Trial.
-
Hybrid therapy of atrial fibrillation.Ital Heart J. 2002 Oct;3(10):571-8. Ital Heart J. 2002. PMID: 12478814 Review.
-
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340. Health Technol Assess. 2008. PMID: 19036232 Review.
Cited by
-
Pulsed Field Ablation of Atrial Fibrillation: A Novel Technology for Safer and Faster Ablation.Biomedicines. 2024 Sep 30;12(10):2232. doi: 10.3390/biomedicines12102232. Biomedicines. 2024. PMID: 39457545 Free PMC article. Review.
-
Usefulness of empiric superior vena cava isolation in paroxysmal atrial fibrillation ablation: a meta-analysis of randomized clinical trials.J Interv Card Electrophysiol. 2024 Aug 9. doi: 10.1007/s10840-024-01867-y. Online ahead of print. J Interv Card Electrophysiol. 2024. PMID: 39120637
-
Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis.BMC Cardiovasc Disord. 2024 Jun 25;24(1):321. doi: 10.1186/s12872-024-03983-z. BMC Cardiovasc Disord. 2024. PMID: 38918704 Free PMC article.
-
Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation.J Geriatr Cardiol. 2024 Mar 28;21(3):251-314. doi: 10.26599/1671-5411.2024.03.009. J Geriatr Cardiol. 2024. PMID: 38665287 Free PMC article.
-
Comparing pulsed field electroporation and radiofrequency ablation for the treatment of paroxysmal atrial fibrillation: design and rationale of the BEAT PAROX-AF randomized clinical trial.Europace. 2024 May 2;26(5):euae103. doi: 10.1093/europace/euae103. Europace. 2024. PMID: 38646926 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical